Neovasc Inc (US) (NVCN) Shares Up 9.1%

Neovasc Inc (US) (NASDAQ:NVCN) (TSE:NVC)’s share price traded up 9.1% during trading on Wednesday . The company traded as high as $0.60 and last traded at $0.60. 811,316 shares changed hands during mid-day trading, an increase of 56% from the average session volume of 519,224 shares. The stock had previously closed at $0.55.

A number of equities analysts have recently commented on the company. ValuEngine lowered Neovasc Inc (US) from a “sell” rating to a “strong sell” rating in a report on Friday, December 1st. Zacks Investment Research lowered Neovasc Inc (US) from a “buy” rating to a “hold” rating in a report on Wednesday, October 18th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. Neovasc Inc (US) presently has an average rating of “Hold” and a consensus price target of $5.19.

The firm has a market cap of $46.96, a P/E ratio of 2.20 and a beta of -0.07.

An institutional investor recently bought a new position in Neovasc Inc (US) stock. Virtu KCG Holdings LLC acquired a new stake in shares of Neovasc Inc (US) (NASDAQ:NVCN) (TSE:NVC) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 108,132 shares of the medical equipment provider’s stock, valued at approximately $149,000. Virtu KCG Holdings LLC owned 0.14% of Neovasc Inc (US) as of its most recent filing with the Securities and Exchange Commission (SEC). 19.04% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Neovasc Inc (US) (NVCN) Shares Up 9.1%” was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at

Neovasc Inc (US) Company Profile

Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.

Receive News & Ratings for Neovasc Inc (US) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc Inc (US) and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit